Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / COMMON STOCK, $0.001 PAR VALUE
-
Shares outstanding
-
14.5M
-
Number of holders
-
22
-
Total 13F shares, excl. options
-
1.61M
-
Shares change
-
+1.2M
-
Total reported value, excl. options
-
$1.38M
-
Value change
-
+$1.05M
-
Number of buys
-
11
-
Number of sells
-
-6
-
Price
-
$0.86
Significant Holders of AETHLON MEDICAL INC - COMMON STOCK, $0.001 PAR VALUE (AEMD) as of Q4 2024
26 filings reported holding AEMD - AETHLON MEDICAL INC - COMMON STOCK, $0.001 PAR VALUE as of Q4 2024.
AETHLON MEDICAL INC - COMMON STOCK, $0.001 PAR VALUE (AEMD) has 22 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.61M shares
of 14.5M outstanding shares and own 11.1% of the company stock.
Largest 10 shareholders include Ikarian Capital, LLC (750K shares), UBS Group AG (250K shares), BOOTHBAY FUND MANAGEMENT, LLC (217K shares), GEODE CAPITAL MANAGEMENT, LLC (110K shares), Virtu Financial LLC (94.2K shares), Sassicaia Capital Advisers LLC (36K shares), Allegiance Financial Group Advisory Services LLC (30K shares), RENAISSANCE TECHNOLOGIES LLC (29.3K shares), Scientech Research LLC (22.6K shares), and TWO SIGMA INVESTMENTS, LP (22.6K shares).
This table shows the top 22 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.